Retour
Fourchette du Jour
40,50 €
42,02 €
Fourchette 52 Semaines
30,08 €
62,18 €
Volume
384 872
Moyenne 50J / 200J
41,39 €
/
47,11 €
Clôture Précédente
42,11 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -6,1 | 0,3 |
| P/B | 8,5 | 2,9 |
| ROE % | -132,9 | 3,7 |
| Net Margin % | -89,9 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
56,88 €
+39.0%
Low: 50,00 €
High: 68,00 €
P/E Prévisionnel
21,7
BPA Prévisionnel
1,94 €
Croissance BPA (est.)
+0,0%
CA Est.
740 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
3,79 €
3,68 € – 3,93 €
|
1,4 B | 1 |
| FY2029 |
3,38 €
3,29 € – 3,50 €
|
1,2 B | 1 |
| FY2028 |
3,01 €
2,81 € – 3,21 €
|
1 B | 2 |
Points Clés
Debt/Equity of 0,02 — conservative balance sheet
Generating 170,73M in free cash flow
Capital efficient — spends only 0,12% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)50,58%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-132,86%
ROIC-106,00%
Net Margin-89,86%
Op. Margin-92,94%
Sécurité
Debt / Equity
0,02
Current Ratio1,47
Interest Coverage0,00
Valorisation
P/E Ratio
-6,10
P/B Ratio8,51
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 50,58% | Revenue Growth (3Y) | 41,71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 587,86M | Net Income (TTM) | -528,26M |
| ROE | -132,86% | ROA | -70,93% |
| Gross Margin | 79,65% | Operating Margin | -92,94% |
| Net Margin | -89,86% | Free Cash Flow (TTM) | 170,73M |
| ROIC | -106,00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 1,47 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,10 | P/B Ratio | 8,51 |
| P/S Ratio | 5,48 | PEG Ratio | 0,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,22B | Enterprise Value | 3,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 587,86M | 390,40M | 292,73M |
| Net Income | -528,26M | -11,93M | -108,14M |
| EPS (Diluted) | -5,19 | -0,15 | -1,39 |
| Gross Profit | 468,22M | 300,59M | 194,18M |
| Operating Income | -546,37M | -24,43M | -130,51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 744,76M | 673,26M | 622,53M |
| Total Liabilities | 366,23M | 256,56M | 195,25M |
| Shareholders' Equity | 378,54M | 416,70M | 427,28M |
| Total Debt | 8,04M | 11,07M | 15,73M |
| Cash & Equivalents | 208,00M | 300,79M | 234,95M |
| Current Assets | 533,90M | 583,45M | 529,88M |
| Current Liabilities | 362,41M | 249,30M | 184,16M |